Teijin
Teijin Ltd is a Japanese chemical and technology conglomerate operating across synthetic fibers, carbon fiber composites, pharmaceuticals, and healthcare products. The company manufactures carbon fiber materials, aramid technical yarns, polycarbonate resins, respiratory healthcare equipment, and pharmaceuticals for osteoporosis and gout. Principal revenues are generated through global sales of high-performance materials and advanced composites alongside pharmaceutical and home healthcare product distribution. Core end markets encompass commercial aerospace builders, automotive OEMs, electronics assemblers, medical patients, and industrial processing plants worldwide. Teijin holds a market-leading global position in high-performance aramid fibers and carbon fiber composites. The corporation is headquartered in Tokyo and Osaka, Japan, and its shares trade on the Tokyo Stock Exchange.
7 of the funds FundTelligence covers report a position in Teijin.
- Legal name
- Teijin Ltd
- Sector
- Materials
- Country
- Japan
- Funds holding it
- 7
Funds holding Teijin
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.07 % (full portfolio disclosed, September 2026)
- Storebrand Global Multifactor — Storebrand · 0.04 % (full portfolio disclosed, October 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)
- Nordea Internationale aktier — Nordea Funds · 0.0 % (full portfolio disclosed, September 2026)
- SEB Active 20 — SEB · 0.0 % (full portfolio disclosed, June 2026)